Structures by: Bowes K. F.
Total: 52
C14H28N4O9RuS3
C14H28N4O9RuS3
Chemical Communications (Cambridge, United Kingdom) (2006) 23 2448-2450
a=6.655(3)Å b=13.109(6)Å c=13.715(6)Å
α=91.663(4)° β=96.450(4)° γ=104.721(4)°
[Ru(NH3)4(H2O)(SO2)][CH3C6H4SO3]2
C14H28N4O9RuS3
Chemical Communications (Cambridge, United Kingdom) (2006) 23 2448-2450
a=6.670(3)Å b=13.076(5)Å c=13.586(5)Å
α=94.352(4)° β=92.738(4)° γ=103.482(4)°
1,4-Diazabicyclo[2.2.2]octane--phosphonoacetic acid (1/1)
C6H12N2,C2H5O5P
Acta Crystallographica Section B (2003) 59, 1 87-99
a=20.3011(17)Å b=6.7692(5)Å c=8.0158(6)Å
α=90.00° β=90.00° γ=90.00°
2,2'-Dipyridylamine--fumaric acid (1/1)
C10H10N3,C4H3O4
Acta Crystallographica Section B (2003) 59, 1 100-117
a=8.0021(4)Å b=8.7178(4)Å c=10.8497(4)Å
α=106.257(3)° β=109.127(3)° γ=98.662(2)°
2,2'-Bipyridyl--fumaric acid (1/1)
C10H8N2,C4H4O4
Acta Crystallographica Section B (2003) 59, 1 100-117
a=23.9702(6)Å b=3.74160(10)Å c=14.8372(4)Å
α=90.00° β=90.00° γ=90.00°
Triphenylsilanol--4,4-bipyridyl (1/1)
C18H16OSi,C10H8N2
Acta Crystallographica Section B (2003) 59, 2 277-286
a=8.9849(3)Å b=9.3118(4)Å c=15.2451(7)Å
α=83.2841(18)° β=89.1384(17)° γ=64.6930(10)°
2,6-Dimethylpiperazine--phosphonopropionic acid--methanol (1/2/0.34)
C6H16N22,2(C3H6O5P1),0.3(CH4O)
Acta Crystallographica Section B (2003) 59, 2 248-262
a=20.2229(17)Å b=8.6162(6)Å c=11.8812(9)Å
α=90.00° β=90.00° γ=90.00°
4,4'-Bipyridyl--phosphonoacetic acid (1/1)
C10H9N2,C2H4O5P
Acta Crystallographica Section B (2003) 59, 1 87-99
a=4.6225(2)Å b=17.2421(6)Å c=15.6529(7)Å
α=90.00° β=95.7190(15)° γ=90.00°
1,3-trimethylenedipiperidine--phosphonoacetic acid (1/1) methanol/water solvate
2(C13H28N2)2(C2H3O5P),1.58(H2O)0.70(CH4O)
Acta Crystallographica Section B (2003) 59, 1 87-99
a=11.7486(3)Å b=13.3913(4)Å c=13.8206(5)Å
α=96.9260(17)° β=109.4140(16)° γ=105.4830(15)°
Meso-5,5,7,12,12,14-Hexa-C-methyl-1,4,8,11- tetraazacyclotetradecane--phosphonoacetic acid (1/2)
C16H38N4,2(C2H4O5P)
Acta Crystallographica Section B (2003) 59, 1 87-99
a=8.7219(2)Å b=9.89470(10)Å c=9.9343(2)Å
α=62.5110(9)° β=85.6800(8)° γ=67.1910(9)°
2,2'-Dipyridylamine--phosphonoacetic acid (1/1)
C10H10N3,C2H4O5P
Acta Crystallographica Section B (2003) 59, 1 87-99
a=7.0706(2)Å b=10.6500(3)Å c=10.7020(4)Å
α=115.8690(13)° β=98.8120(15)° γ=104.0040(13)°
1,2-Bis(4'-pyridyl)ethane--phosphonoacetic acid (1/2)
C12H14N2,2(C2H4O5P)
Acta Crystallographica Section B (2003) 59, 1 87-99
a=8.8501(3)Å b=15.1862(6)Å c=7.3741(3)Å
α=90.00° β=90.761(2)° γ=90.00°
1,2-Bis(4-pyridyl)ethane--maleic acid (1/2)
C12H14N2,2(C4H3O4)
Acta Crystallographica Section B (2003) 59, 1 100-117
a=5.7958(3)Å b=9.4489(6)Å c=9.6031(7)Å
α=86.787(3)° β=73.010(3)° γ=76.986(3)°
4,4'-Bipyridyl--maleic acid (1/2)
C10H10N2,2(C4H3O4)
Acta Crystallographica Section B (2003) 59, 1 100-117
a=24.0370(16)Å b=6.7434(6)Å c=11.4388(10)Å
α=90.00° β=115.996(4)° γ=90.00°
1,4-Diazabicyclo[2.2.2]octane--fumaric acid (1/2)
C6H14N2,2(C4H3O4)
Acta Crystallographica Section B (2003) 59, 1 100-117
a=20.1118(9)Å b=6.4737(4)Å c=12.5409(7)Å
α=90.00° β=115.070(2)° γ=90.00°
1,4-Diazabicyclo[2.2.2]octane--fumaric acid (1/1)
C6H13.57N2,C4H2.43O4
Acta Crystallographica Section B (2003) 59, 1 100-117
a=9.6845(2)Å b=8.8805(2)Å c=12.5886(2)Å
α=90.00° β=100.0697(15)° γ=90.00°
4,4'-Bipyridyl--fumaric acid (1/1)
C10H8N2,C4H4O4
Acta Crystallographica Section B (2003) 59, 1 100-117
a=3.8040(2)Å b=8.8743(5)Å c=9.8764(6)Å
α=109.757(2)° β=97.246(3)° γ=96.813(3)°
1,2-Bis(4-pyridyl)ethane--fumaric acid (1/1)
C12H12N2,C4H4O4
Acta Crystallographica Section B (2003) 59, 1 100-117
a=21.0296(14)Å b=4.7456(3)Å c=16.6875(11)Å
α=90.00° β=118.394(3)° γ=90.00°
4,4'-trimethylenedipyridine--fumaric acid (1/1)
C13H14N2,C4H4O4
Acta Crystallographica Section B (2003) 59, 1 100-117
a=22.4349(15)Å b=4.6045(3)Å c=17.1156(12)Å
α=90.00° β=116.465(3)° γ=90.00°
2,2'-Dipyridylamine--maleic acid (1/2)
C10H10N3,C8H7O8
Acta Crystallographica Section B (2003) 59, 1 100-117
a=11.566(2)Å b=5.4392(11)Å c=14.334(3)Å
α=90.00° β=99.03(3)° γ=90.00°
Hexamethylenetetramine--fumaric acid--succinic acid (1/0.726/0.224)
C6H12N4,0.726(C4H4O4),0.274(C4H6O4)
Acta Crystallographica Section B (2003) 59, 1 100-117
a=6.2877(2)Å b=15.9241(6)Å c=11.3315(5)Å
α=90.00° β=93.8556(13)° γ=90.00°
1,2-Bis(4'-pyridyl)ethene--phosphonopropionic acid (1/1)
C12H12N22,C12H10N2,2(C3H6O5P)1
Acta Crystallographica Section B (2003) 59, 2 248-262
a=10.1600(3)Å b=10.4061(3)Å c=14.5441(5)Å
α=90.00° β=96.2880(12)° γ=90.00°
2,2'-Dipyridylamine--phosphonopropionic acid--water (1/1/1)
C10H10N31,C3H6O5P1,H2O
Acta Crystallographica Section B (2003) 59, 2 248-262
a=18.7267(11)Å b=22.6805(11)Å c=7.0893(4)Å
α=90.00° β=90.00° γ=90.00°
Piperazine--phosphonopropionic acid (1/1)
C4H12N22,C3H5O5P2
Acta Crystallographica Section B (2003) 59, 2 248-262
a=10.6065(3)Å b=7.9214(2)Å c=12.8892(4)Å
α=90.00° β=94.0540(12)° γ=90.00°
N,N'-Dimethylpiperazine--phosphonopropionic acid--water (1/2/2)
C6H16N22,2(C3H6O5P1),2(H2O)
Acta Crystallographica Section B (2003) 59, 2 248-262
a=6.9270(2)Å b=20.6027(5)Å c=8.0115(2)Å
α=90.00° β=111.4092(10)° γ=90.00°
4,4'-Bipyridyl--phosphonopropionic acid (1/1)
C10H8.82N20.72,C3H6O5.28P0.72=
Acta Crystallographica Section B (2003) 59, 2 248-262
a=11.3482(5)Å b=6.7178(3)Å c=17.7354(7)Å
α=90.00° β=97.4980(18)° γ=90.00°
Triphenylsilanol--4,4'-bipyridyl (4/1), polymorph with Z' = 0.5
4(C18H16OSi),C10H8N2
Acta Crystallographica Section B (2003) 59, 2 277-286
a=9.2128(18)Å b=10.244(2)Å c=19.036(4)Å
α=99.65(3)° β=93.21(3)° γ=99.57(3)°
Triphenylsilanol--4,4'-bipyridyl (4/1), polymorph with Z' = 1
4(C18H16OSi),C10H8N2
Acta Crystallographica Section B (2003) 59, 2 277-286
a=10.1595(19)Å b=18.370(4)Å c=20.490(4)Å
α=66.75(3)° β=77.35(3)° γ=80.95(3)°
Triphenylsilanol--4,4'-bipyridyl (4/1), polymorph with Z' = 4
4(C18H16OSi),C10H8N2
Acta Crystallographica Section B (2003) 59, 2 277-286
a=20.787(4)Å b=24.404(5)Å c=29.456(6)Å
α=83.68(3)° β=89.65(3)° γ=67.11(3)°
1,2-Bis(4'-pyridyl)ethane--phosphonopropionic acid (1/2)
C12H14N22,2(C3H6O5P1)
Acta Crystallographica Section B (2003) 59, 2 248-262
a=7.5651(3)Å b=8.6472(3)Å c=9.0077(4)Å
α=72.6340(14)° β=73.1760(15)° γ=87.386(2)°
2,3,5-Trichloro-6-(4-methylpiperidin-1-yl)-1,4-benzoquinone
C12H12Cl3NO2
Acta Crystallographica Section E (2005) 61, 3 o696-o698
a=6.9577(14)Å b=9.3611(19)Å c=10.724(2)Å
α=70.64(3)° β=83.96(3)° γ=82.27(3)°
1,4,8,11-Tetraazoniacyclotetradecane tetrakis-phenylphosphonate dihydrate
C10H28N44,4C6H6O3P1,2H2O
Acta Crystallographica Section C (2003) 59, 8 o461-o463
a=13.0678(3)Å b=8.7475(2)Å c=17.6106(5)Å
α=90.00° β=90.5130(11)° γ=90.00°
4,4'-Trimethylenedipyridinium bis[carboxymethylphosphonate(1-)]
C13H16N22,2C2H4O5P1
Acta Crystallographica Section C (2003) 59, 8 o464-o466
a=27.366(2)Å b=32.347(2)Å c=4.8818(3)Å
α=90.00° β=90.00° γ=90.00°
Bis(triphenylsilanol) dimethyl sulfoxide solvate
2C18H16OSi,C2H6OS
Acta Crystallographica Section C (2002) 58, 7 o409-o415
a=16.8842(3)Å b=8.5391(2)Å c=23.7053(6)Å
α=90° β=96.1310(10)° γ=90°
Tetrakis(triphenylsilanol) 1,4-dioxan solvate
4C18H16OSi,C4H8O2
Acta Crystallographica Section C (2002) 58, 7 o409-o415
a=9.3033(3)Å b=11.6929(5)Å c=14.7154(6)Å
α=87.730(3)° β=80.906(3)° γ=87.8040(17)°
Triphenylsilanol
C18H16OSi
Acta Crystallographica Section C (2002) 58, 7 o409-o415
a=15.0514(2)Å b=19.5456(2)Å c=23.0921(6)Å
α=108.0455(5)° β=102.7869(6)° γ=101.3081(8)°
N,N'-Dithiobisphthalimide--nitrobenzene (2/1)
2C16H8N2O4S2,C6H5NO2
Acta Crystallographica Section C (2002) 58, 9 o551-o554
a=7.7070(2)Å b=16.1001(3)Å c=14.3067(4)Å
α=90.00° β=95.0770(10)° γ=90.00°
1,4-diazoniabicyclo[2.2.2]octane-N-[(hydroxyphosphinato)methyl]iminiodiacetate -water (1/1/1.5
C6H14N22,C5H8NO7P2,1.5H2O
Acta Crystallographica Section C (2002) 58, 8 o467-o469
a=14.1042(5)Å b=7.0560(3)Å c=16.4004(7)Å
α=90° β=90.1130(18)° γ=90°
2-Amino-4-chloro-6-morpholinopyrimidine, Z' = 1 polymorph
C8H11ClN4O
Acta Crystallographica Section C (2003) 59, 1 o4-o8
a=9.4143(4)Å b=13.0869(4)Å c=7.5774(2)Å
α=90.00° β=96.4260(13)° γ=90.00°
2-Amino-4-chloro-6-morpholinopyrimidine, Z' = 2 polymorph
C8H11ClN4O
Acta Crystallographica Section C (2003) 59, 1 o4-o8
a=13.9215(3)Å b=8.1803(2)Å c=19.6390(4)Å
α=90.00° β=121.6130(12)° γ=90.00°
2-Amino-4-chloro-6-piperidinopyrimidine
C9H13ClN4
Acta Crystallographica Section C (2003) 59, 1 o4-o8
a=13.8139(2)Å b=8.48040(10)Å c=19.8379(3)Å
α=90.00° β=120.6770(9)° γ=90.00°
Benzanilide
C13H11NO
Acta Crystallographica Section C (2003) 59, 1 o1-o3
a=5.3406(5)Å b=7.7727(7)Å c=12.3901(15)Å
α=72.702(3)° β=79.389(3)° γ=89.914(5)°
Meso-5,5,7,12,12,14-hexamethyl-1,4-diaza-8,11-diazoniumcyclotetradecane bis(2-naphthoate) ethanol disolvate
C16H38N42,2C11H7O2,2C2H6O
Acta Crystallographica Section C (2003) 59, 3 o147-o149
a=10.9563(4)Å b=10.9584(5)Å c=17.1665(8)Å
α=90° β=101.446(2)° γ=90°
Meso-5,5,7,12,12,14-Hexamethyl-4,11-diaza-1,8-diazoniacyclotetradecane (S)-malate(2-) methanol disolvate
C16H38N42,C4H4O52,2CH4O
Acta Crystallographica Section C (2003) 59, 6 o329-o331
a=8.6559(9)Å b=9.3275(9)Å c=10.1044(12)Å
α=113.379(5)° β=108.908(4)° γ=100.345(4)°
N,N'-Dithiodiphthalimide--1,4-dioxan (1/0.6)
3C16H8N2O4S2,1.8C4H8O2
Acta Crystallographica Section C (2002) 58, 6 o347-o350
a=20.7900(11)Å b=16.0520(10)Å c=16.7780(9)Å
α=90° β=105.604(4)° γ=90°
Iridium 2
C33H27IrN2O2S2
Crystal Growth & Design (2013) 13, 5 1826
a=10.08770(10)Å b=18.2730(2)Å c=30.8642(3)Å
α=90.00° β=90.00° γ=90.00°
Iridium 1
C33H21F6IrN2O2S2
Crystal Growth & Design (2013) 13, 5 1826
a=12.449(3)Å b=17.904(4)Å c=27.691(6)Å
α=90.00° β=90.00° γ=90.00°
Iridium 3
C31H21F2IrN2O2S2
Crystal Growth & Design (2013) 13, 5 1826
a=17.1215(2)Å b=17.2024(2)Å c=18.1350(3)Å
α=90.00° β=90.00° γ=90.00°
Iridium 4
C31H21F2IrN2O2S2
Crystal Growth & Design (2013) 13, 5 1826
a=11.78520(10)Å b=21.8859(2)Å c=21.4317(2)Å
α=90.00° β=97.2931(5)° γ=90.00°
Iridium 6
C33H27IrN2O4S2
Crystal Growth & Design (2013) 13, 5 1826
a=10.8570(2)Å b=16.1514(4)Å c=17.1152(4)Å
α=90.00° β=106.9820(14)° γ=90.00°
Iridium 7
C34H18F6IrN3O2.88S2
Crystal Growth & Design (2013) 13, 5 1826
a=16.951(3)Å b=17.985(4)Å c=21.263(4)Å
α=90.00° β=90.00° γ=90.00°
Iridium 5
C31H23IrN2O2S2
Crystal Growth & Design (2013) 13, 5 1826
a=20.01070(10)Å b=63.6177(6)Å c=17.7788(2)Å
α=90.00° β=106.1941(4)° γ=90.00°